178 related articles for article (PubMed ID: 36866758)
1. [Corrigendum] S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway.
Wu R; Duan L; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L
Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36866758
[TBL] [Abstract][Full Text] [Related]
2. [Corrigendum] SB‑T‑121205, a next‑generation taxane, enhances apoptosis and inhibits migration/invasion in MCF‑7/PTX cells.
Zheng X; Wang C; Xing Y; Chen S; Meng T; You H; Ojima I; Dong Y
Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36484397
[TBL] [Abstract][Full Text] [Related]
3. [Corrigendum] miR‑200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non‑small cell lung cancer cells.
Tang Q; Li M; Chen L; Bi F; Xia H
Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36196896
[TBL] [Abstract][Full Text] [Related]
4. [Corrigendum] Genistein exerts growth inhibition on human osteosarcoma MG-63 cells via PPARγ pathway.
Song M; Tian X; Lu M; Zhang X; Ma K; Lv Z; Wang Z; Hu Y; Xun C; Zhang Z; Wang S
Int J Oncol; 2024 May; 64(5):. PubMed ID: 38488025
[TBL] [Abstract][Full Text] [Related]
5. [Corrigendum] DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway.
Jin F; Wang H; Li D; Fang C; Li W; Shi Q; Diao Y; Ding Z; Dai X; Tao L; Sunagawa M; Wu F; Qian Y; Liu Y
Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35147201
[TBL] [Abstract][Full Text] [Related]
6. [Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
Ji J; Shen I; Li Y; Liu Y; Shang Z; Niu Y
Oncol Rep; 2023 Sep; 50(3):. PubMed ID: 37477123
[TBL] [Abstract][Full Text] [Related]
7. [Corrigendum] Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer.
Song H; Dong M; Zhou J; Sheng W; Li X; Gao W
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36069219
[TBL] [Abstract][Full Text] [Related]
8. [Corrigendum] Identification of lncRNA EGOT as a tumor suppressor in renal cell carcinoma.
Jin L; Quan J; Pan X; He T; Hu J; Li Y; Gui Y; Yang S; Mao X; Chen Y; Lai Y
Mol Med Rep; 2024 May; 29(5):. PubMed ID: 38456482
[TBL] [Abstract][Full Text] [Related]
9. [Corrigendum] Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer.
Abukiwan A; Nwaeburu CC; Bauer N; Zhao Z; Liu L; Gladkich J; Gross W; Benner A; Strobel O; Fellenberg J; Herr I
Int J Oncol; 2023 Aug; 63(2):. PubMed ID: 37417373
[TBL] [Abstract][Full Text] [Related]
10. [Corrigendum] Deoxypodophyllotoxin inhibits cell viability and invasion by blocking the PI3K/Akt signaling pathway in human glioblastoma cells.
Wang W; Gao W; Zhang L; Zhang D; Zhao Z; Bao Y
Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36660948
[TBL] [Abstract][Full Text] [Related]
11. [Corrigendum] microRNA‑181a‑5p functions as an oncogene in renal cell carcinoma.
Lai Y; Zhao L; Hu J; Quan J; Chen P; Xu J; Guan X; Lai Y; Ni L
Mol Med Rep; 2024 Apr; 29(4):. PubMed ID: 38362959
[TBL] [Abstract][Full Text] [Related]
12. [Corrigendum] Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway.
Sun X; Xin S; Zhang Y; Jin L; Liu X; Zhang J; Mei W; Zhang B; Ma W; Ye L
Int J Oncol; 2024 Jan; 64(1):. PubMed ID: 38038145
[TBL] [Abstract][Full Text] [Related]
13. [Corrigedum] miR‑185 inhibits non‑small cell lung cancer cell proliferation and invasion through targeting of SOX9 and regulation of Wnt signaling.
Lei Z; Shi H; Li W; Yu D; Shen F; Yu X; Lu D; Sun C; Liao K
Mol Med Rep; 2023 May; 27(5):. PubMed ID: 36960863
[TBL] [Abstract][Full Text] [Related]
14. [Corrigendum] Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway.
Zhang X; Liu N; Ma D; Liu L; Jiang L; Zhou Y; Zeng X; Li J; Chen Q
Int J Oncol; 2022 Feb; 60(2):. PubMed ID: 34981815
[TBL] [Abstract][Full Text] [Related]
15. [Corrigendum] Repression of Smad4 by miR‑205 moderates TGF‑β-induced epithelial‑mesenchymal transition in A549 cell lines.
Zeng Y; Zhu J; Shen D; Qin H; Lei Z; Li W; Huang JA; Liu Z
Int J Oncol; 2021 Feb; 58(2):276-277. PubMed ID: 33491753
[TBL] [Abstract][Full Text] [Related]
16. [Corrigendum] Benzyl isothiocyanate suppresses development and metastasis of murine mammary carcinoma by regulating the Wnt/β‑catenin pathway.
Xie B; Zhao L; Guo L; Liu H; Fu S; Fan W; Lin L; Chen J; Wang B; Fan L; Wei H
Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 35946456
[TBL] [Abstract][Full Text] [Related]
17. [Corrigendum] Downregulation of miR‑637 promotes proliferation and metastasis by targeting Smad3 in keloids.
Zhang Y; Guo B; Hui Q; Li W; Chang P; Tao K
Mol Med Rep; 2023 Oct; 28(4):. PubMed ID: 37681449
[TBL] [Abstract][Full Text] [Related]
18. [Corrigendum] miR‑593 inhibits proliferation and invasion and promotes apoptosis in non‑small cell lung cancer cells by targeting SLUG‑associated signaling pathways.
Wei F; Wang M; Li Z; Wang Y; Zhou Y
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34878153
[TBL] [Abstract][Full Text] [Related]
19. [Corrigendum] miR‑195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression.
Cai C; He H; Duan X; Wu W; Mai Z; Zhang T; Fan J; Deng T; Zhong W; Liu Y; Zhong W; Zeng G
Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36825583
[TBL] [Abstract][Full Text] [Related]
20. [Corrigendum] STMN1, a prognostic predictor of esophageal squamous cell carcinoma, is a marker of the activation of the PI3K pathway.
Jiang W; Huang S; Song L; Wang Z
Oncol Rep; 2021 Jan; 45(1):401-402. PubMed ID: 33200224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
